HomeCompareCLDHF vs ARCC

CLDHF vs ARCC: Dividend Comparison 2026

CLDHF yields 6.26% · ARCC yields 10.82%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CLDHF wins by $38.8K in total portfolio value
10 years
CLDHF
CLDHF
● Live price
6.26%
Share price
$0.60
Annual div
$0.04
5Y div CAGR
20.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$63.3K
Annual income
$10,502.68
Full CLDHF calculator →
ARCC
Ares Capital Corporation
● Live price
10.82%
Share price
$17.74
Annual div
$1.92
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.5K
Annual income
$1.16
Full ARCC calculator →

Portfolio growth — CLDHF vs ARCC

📍 CLDHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCLDHFARCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CLDHF + ARCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CLDHF pays
ARCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CLDHF
Annual income on $10K today (after 15% tax)
$532.25/yr
After 10yr DRIP, annual income (after tax)
$8,927.28/yr
ARCC
Annual income on $10K today (after 15% tax)
$919.95/yr
After 10yr DRIP, annual income (after tax)
$0.99/yr
At 15% tax rate, CLDHF beats the other by $8,926.29/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CLDHF + ARCC for your $10,000?

CLDHF: 50%ARCC: 50%
100% ARCC50/50100% CLDHF
Portfolio after 10yr
$43.9K
Annual income
$5,251.92/yr
Blended yield
11.95%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ARCC right now

CLDHF
No analyst data
Altman Z
0.4
Piotroski
6/9
ARCC
Analyst Ratings
24
Buy
7
Hold
Consensus: Buy
Price Target
$21.88
+23.3% upside vs current
Range: $21.00 — $23.00
Altman Z
0.8
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CLDHF buys
0
ARCC buys
0
No recent congressional trades found for CLDHF or ARCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCLDHFARCC
Forward yield6.26%10.82%
Annual dividend / share$0.04$1.92
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR20.1%-50%
Portfolio after 10y$63.3K$24.5K
Annual income after 10y$10,502.68$1.16
Total dividends collected$36.8K$1.1K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: CLDHF vs ARCC ($10,000, DRIP)

YearCLDHF PortfolioCLDHF Income/yrARCC PortfolioARCC Income/yrGap
1← crossover$11,452$752.04$11,381$541.15+$71.00CLDHF
2$13,220$966.69$12,621$284.08+$599.00CLDHF
3$15,398$1,252.58$13,827$145.31+$1.6KCLDHF
4$18,114$1,637.55$15,062$73.43+$3.1KCLDHF
5$21,544$2,162.17$16,364$36.89+$5.2KCLDHF
6$25,938$2,886.45$17,757$18.49+$8.2KCLDHF
7$31,655$3,900.70$19,258$9.25+$12.4KCLDHF
8$39,214$5,343.16$20,880$4.63+$18.3KCLDHF
9$49,388$7,429.45$22,636$2.32+$26.8KCLDHF
10$63,348$10,502.68$24,539$1.16+$38.8KCLDHF

CLDHF vs ARCC: Complete Analysis 2026

CLDHFStock

CapitaLand China Trust (CLCT), formerly known as CapitaLand Retail China Trust, is Singapore's largest China-focused real estate investment trust (REIT). Upon completion of the transformational acquisition of five business parks and balance 49% interest in Rock Square, CLCT's enlarged portfolio will comprise of 13 shopping malls and five business park properties. The geographically diversified portfolio has a total gross floor area (GFA) of approximately 1.8 million square metre (sq m), located across 11 leading Chinese cities. CLCT was listed on the Singapore Exchange Securities Trading Limited (SGX-ST) on 8 December 2006, and established with the objective of investing on a long-term basis in a diversified portfolio of income-producing real estate and real estate-related assets in mainland China, Hong Kong and Macau that are used primarily for retail, office and industrial purposes (including business parks, logistics facilities, data centres and integrated developments). CLCT's retail properties are strategically located in densely populated areas with good connectivity to public transport. The malls are positioned as one-stop family-oriented destinations housing a wide range of lifestyle offerings that cater to varied consumer preferences in shopping, dining and entertainment as well as essential services. CLCT's portfolio comprises a diverse mix of more than 2,000 leases, which include leading brands UNIQLO, Xiaomi, ZARA, Haidilao, Nike, Sephora, Starbucks Coffee and Swarovski. The malls are CapitaMall Xizhimen, CapitaMall Wangjing, CapitaMall Grand Canyon and CapitaMall Shuangjing in Beijing; Rock Square in Guangzhou; CapitaMall Xinnan in Chengdu; CapitaMall Qibao in Shanghai; CapitaMall Minzhongleyuan in Wuhan; CapitaMall Saihan and CapitaMall Nuohemule in Hohhot; CapitaMall Xuefu, CapitaMall Aidemengdun in Harbin and CapitaMall Yuhuating in Changsha. CLCT has a portfolio of five business parks situated in high-growth economic zones which house high quality and reputable domestic and multinational corporations operating in new economy sectors such as Electronics, Engineering, E-Commerce, Information and Communications Technology and Financial Services. The business parks exhibit excellent connectivity with close proximity to transportation hubs, and are easily accessible via various modes of transportation. The properties are Ascendas Xinsu Portfolio in Suzhou, Ascendas Innovation Towers and Ascendas Innovation Hub in Xi'an and Singapore-Hangzhou Science & Technology Park Phase I and Phase II in Hangzhou. CLCT is managed by CapitaLand China Trust Management Limited, a wholly owned subsidiary of Singapore-listed CapitaLand Limited, one of Asia's largest diversified real estate groups.

Full CLDHF Calculator →

ARCCBDC

Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors. The fund will also consider investments in industries such as restaurants, retail, oil and gas, and technology sectors. It focuses on investments in Northeast, Mid-Atlantic, Southeast and Southwest regions from its New York office, the Midwest region, from the Chicago office, and the Western region from the Los Angeles office. The fund typically invests between $20 million and $200 million and a maximum of $400 million in companies with an EBITDA between $10 million and $250 million. It makes debt investments between $10 million and $100 million The fund invests through revolvers, first lien loans, warrants, unitranche structures, second lien loans, mezzanine debt, private high yield, junior capital, subordinated debt, and non-control preferred and common equity. The fund also selectively considers third-party-led senior and subordinated debt financings and opportunistically considers the purchase of stressed and discounted debt positions. The fund prefers to be an agent and/or lead the transactions in which it invests. The fund also seeks board representation in its portfolio companies.

Full ARCC Calculator →
📬

Get this CLDHF vs ARCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CLDHF vs SCHDCLDHF vs JEPICLDHF vs OCLDHF vs KOCLDHF vs MAINCLDHF vs HTGCCLDHF vs GBDCCLDHF vs ORCC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.